- We re-affirm our BUY rating on MBM, with an unchanged fair
value of RM5.40/share, following a chat with management recently regarding its
vehicle manufacturing JV with Hino.
- We gather that the recently-announced JV with Hino (refer
to report dated 1 Oct 2012 for details) will utilise a brand new licence
dedicated for Hino. Under the 2009 NAP review, holders of new licences are
allowed to manufacture any type of commercial vehicles. We reckon MBM’s “old”
comprehensive licence parked under 70%-owned Kinabalu Motor Assembly will be
better utilised for the manufacture of passenger cars as this is where its
value lies – new licenses only allow manufacturing of >1.8 litre passenger
cars, priced >RM150K.
- The land to be acquired in Sendayan Tech Valley will be
fully utilised for Hino as in the foreseeable future, part of the land will be
utilised as Hino’s stockyard, which will consume a large amount of space. If
required to expand capacity, the stockyard can be moved elsewhere in the
future. Production capacity of 10K/annum is in-line with Hino’s target of
achieving c.10K unit sales in 2014. This will be driven by the launch of a new
line of light truck models, i.e. the Hino 300 series back in April. YTD12 annualised
sales stand at 6,361 units and 2013 sales is targeted to be in the range of
7K-8K before rising to 9K-10K in 2014.
- In regard to the business model, the JV will assume costs
of CKD kits on top of assembly cost and in return, sell the finished products
to Hino Motors (Malaysia) to be distributed to dealers and branches. This means
margins achieved by the JV could be a lot lower than earlier expected given a
higher cost base (and revenue pass through) from CKD kits, but absolute
earnings should be higher than our earlier estimates (of RM2.6mil/annum), which
strictly assumed a contract assembly business model. Our back of the envelope
estimates suggest a 4-5% enhancement to FY14F earnings with a RM10mil/annum contribution
from the JV.
- More importantly, we would not underestimate the spillover
benefits to MBM’s parts manufacturing businesses in providing localisation for
Hino. Three potential beneficiaries are Summit (100%-owned commercial vehicle
upper body manufacturer), OMI (78%-owned steel wheel manufacturer) and Hirotako
(100%- owned safety systems manufacturer). We estimate a 1%-3% enhancement to
the respective unit’s revenues from potential supplies to Hino. In the
meantime, we leave our projections unchanged until there is more concrete
visibility on the JVs earnings prospect.
- We remain bullish on MBM for its strategic move up the
value chain, which may involve new franchise wins and assembly rights,
particularly in the high volume passenger car segment going forward. Such announcements within the next 12 months should
serve as strong share price catalysts, considering MBM’s deeply-discounted
valuation of 7x FY13F earnings vs. peers’ 11-13x.
Source: AmeSecurities
No comments:
Post a Comment